175 related articles for article (PubMed ID: 19816677)
1. Dosing protocol and analgesic efficacy determine opioid tolerance in the mouse.
Madia PA; Dighe SV; Sirohi S; Walker EA; Yoburn BC
Psychopharmacology (Berl); 2009 Dec; 207(3):413-22. PubMed ID: 19816677
[TBL] [Abstract][Full Text] [Related]
2. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
3. The effect of intrinsic efficacy on opioid tolerance.
Duttaroy A; Yoburn BC
Anesthesiology; 1995 May; 82(5):1226-36. PubMed ID: 7741298
[TBL] [Abstract][Full Text] [Related]
4. Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation.
Kumar P; Sunkaraneni S; Sirohi S; Dighe SV; Walker EA; Yoburn BC
Eur J Pharmacol; 2008 Nov; 597(1-3):39-45. PubMed ID: 18789923
[TBL] [Abstract][Full Text] [Related]
5. Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.
Stoops WW; Hatton KW; Lofwall MR; Nuzzo PA; Walsh SL
Psychopharmacology (Berl); 2010 Oct; 212(2):193-203. PubMed ID: 20665209
[TBL] [Abstract][Full Text] [Related]
6. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
Madia PA; Navani DM; Yoburn BC
Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
[TBL] [Abstract][Full Text] [Related]
7. In vivo homologous regulation of mu-opioid receptor gene expression in the mouse.
Sehba F; Duttaroy A; Shah S; Chen B; Carroll J; Yoburn BC
Eur J Pharmacol; 1997 Nov; 339(1):33-41. PubMed ID: 9450614
[TBL] [Abstract][Full Text] [Related]
8. Ethanol Reversal of Tolerance to the Antinociceptive Effects of Oxycodone and Hydrocodone.
Jacob JC; Poklis JL; Akbarali HI; Henderson G; Dewey WL
J Pharmacol Exp Ther; 2017 Jul; 362(1):45-52. PubMed ID: 28442580
[TBL] [Abstract][Full Text] [Related]
9. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
[TBL] [Abstract][Full Text] [Related]
10. Reversal of oxycodone and hydrocodone tolerance by diazepam.
Gonek M; Akbarali HI; Henderson G; Dewey WL
Brain Res; 2017 Nov; 1674():84-90. PubMed ID: 28830768
[TBL] [Abstract][Full Text] [Related]
11. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
Freye E; Latasch L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
[TBL] [Abstract][Full Text] [Related]
12. Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.
Zacny JP; Gutierrez S
Drug Alcohol Depend; 2009 Apr; 101(1-2):107-14. PubMed ID: 19118954
[TBL] [Abstract][Full Text] [Related]
13. Differential analgesic cross-tolerance to morphine between lipophilic and hydrophilic narcotic agonists.
Paktor J; Vaught JL
Life Sci; 1984 Jan; 34(1):13-21. PubMed ID: 6141509
[TBL] [Abstract][Full Text] [Related]
14. Burn injury decreases the antinociceptive effects of opioids.
Emery MA; Bates MLS; Wellman PJ; Eitan S
Behav Pharmacol; 2017 Jun; 28(4):285-293. PubMed ID: 28134661
[TBL] [Abstract][Full Text] [Related]
15. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
Shen KF; Crain SM
Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
[TBL] [Abstract][Full Text] [Related]
16. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
[TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of oxycodone, hydrocodone, and morphine on the responses of D2/D3 dopamine receptors.
Emery MA; Bates ML; Wellman PJ; Eitan S
Behav Brain Res; 2015 May; 284():37-41. PubMed ID: 25617530
[TBL] [Abstract][Full Text] [Related]
19. In vivo regulation of mu-opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice.
Duttaroy A; Yoburn BC
Synapse; 2000 Aug; 37(2):118-24. PubMed ID: 10881033
[TBL] [Abstract][Full Text] [Related]
20. Continuous morphine produces more tolerance than intermittent or acute treatment.
Dighe SV; Madia PA; Sirohi S; Yoburn BC
Pharmacol Biochem Behav; 2009 May; 92(3):537-42. PubMed ID: 19248799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
